Media Releases

2023

08/09/2023

Proteomics blood test primed for cancer fight – The West Australian

04/09/2023

Proteomics International Laboratories Ltd OxiDx Platform Technology Secures Patent in Japan – The West Australian

15/06/2023

Intervention needed to stop kidney disease overwhelming NHS, Kidney Research UK says – Evening Standard

14/06/2023

NHS facing ‘impossible’ challenge to care for kidney disease patients, Kidney Research UK warns – itv

11/06/2023

Kidney disease ‘could become public health emergency’ without more funding, charity warns – sky news

06/06/2023

New Kidney Research UK Report Shows Kidney Disease is a Public Health Emergency

21/05/2023

Heartbreaking impact of endometriosis on women laid bare – The West Australian

18/05/2023

Video Interview – Exclusive Agreement with Sonic Healthcare USA

10/05/2023

Proteomics International & Sonic Healthcare USA sign exclusive licence agreement

10/05/2023

Proteomics seals exclusive deal for kidney test in US – The West Australian

10/05/2023

Proteomics International (ASX:PIQ) inks exclusive licence agreement to bring PromarkerD to the US market – The Market Herald

10/05/2023

Proteomics’ PromarkerD test enters the lucrative US market – THE SENTIMENT

05/05/2023

New diagnostic blood test showcased at world’s premier endometriosis conference

03/05/2023

PromarkerD test scores show treatment with canagliflozin can lessen risk of diabetic kidney disease

26/04/2023

Clinical Advisory Board expanded to support PromarkerD USA and global rollout

1
2
3
4
5
6
7
8
9
…
25